Andrea Downey

Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.

Carolyn Wasserheit, Andrea Frazein, Ruth Oratz et al. · Journal of Clinical Oncology · 1996 · 87 citations

Medicine, Oncology, Pharmacology +15

Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil®): Experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer

Eleni Andreopoulou, Darci Gaiotti, E. Kim et al. · Annals of Oncology · 2007 · 82 citations · Full text

Medicine, Oncology, Pharmacology +16

Squamous Cell Carcinoma of the Oral Cavity in Nonsmoking Women: A New and Unusual Complication of Chemotherapy for Recurrent Ovarian Cancer?

Timothy Lewis Cannon, Dominic W. Lai, David L. Hirsch et al. · The Oncologist · 2012 · 41 citations · Full text

Medicine, Oncology, Chemotherapy +9

Feasibility and Cardiac Safety of Pegylated Liposomal Doxorubicin plus Trastuzumab in Heavily Pretreated Patients with Recurrent HER2-Overexpressing Metastatic Breast Cancer

Eleni Andreopoulou, Darci Gaiotti, Eugene S. Kim et al. · Clinical Breast Cancer · 2007 · 31 citations

Medicine, Oncology, Pharmacology +16

Ovarian Cancer in BRCA Mutation Carriers: Improved Outcome After Intraperitoneal (IP) Cisplatin

Maryann Kwa, Susan Edwards, Andrea Downey et al. · Annals of Surgical Oncology · 2013 · 30 citations

Medicine, Gynecology, Oncology +14